| Summary: | Propiverine modified-release formulation (Mictoryl, MR) and propiverine pediatric (Mictoryl Pediatric) are detrusor relaxant drugs with antimuscarinic and calcium-modulating properties indicated for symptomatic treatment of urinary incontinence and/or increased urinary frequency and urgency in patients with overactive bladder (OAB). Propiverine MR is available in 30 mg and 45 mg capsules, taken once daily, for adults with OAB. Propiverine pediatric is an immediate-release formulation (IR) available in 5 mg tablets for children, with body weight-adjusted dosage to be taken twice daily. The manufacturer has submitted a price of $1.39 per 30 mg or 45 mg MR capsule ($1.39 per day), and $0.37 per 5 mg IR tablet ($0.74 to $2.22 per day). Propiverine IR 15 mg was never marketed in Canada
|
|---|